Recent Advances in Prostate Cancer Imaging and Biopsy Techniques
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 74
Special Issue Editor
Special Issue Information
Dear Colleagues,
There have been remarkable advances in the field of prostate imaging over the last few years, with prostate MRI and PSMA PET being more routinely used in clinical practice for the detection and staging of prostate cancer. In addition, prostate sampling techniques and approaches have evolved significantly, allowing for more accurate sampling of the prostate gland. This Special Issue will collate the latest updates on imaging and biopsy for prostate cancer diagnostics. Potential topics of interest include, but are not limited to, the following:
- Multi-parametric MRI (mpMRI) of prostate;
- Artificial intelligence and prostate MRI;
- PSMA PET in detection and staging of prostate cancer;
- Novel molecular tracers for prostate cancer imaging;
- Magnetic resonance imaging (MRI)–transrectal ultrasound (TRUS) fusion prostate biopsy;
- Transperineal prostate biopsy;
- Future directions regarding prebiopsy imaging.
We are seeking high-quality original research and review articles to include in the collection. Following the initial triage stage, suitable manuscripts submitted to this Special Issue will undergo external peer review.
Dr. Abhinav Sidana
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multi-parametric MRI (mpMRI) of prostate
- artificial intelligence and prostate MRI
- PSMA PET in detection and staging of prostate cancer
- novel molecular tracers for prostate cancer imaging
- magnetic resonance imaging (MRI)–transrectal ultrasound (TRUS) fusion prostate biopsy
- transperineal prostate biopsy
- future directions regarding prebiopsy imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
